Adriforant
Adriforant Uses, Dosage, Side Effects, Food Interaction and all others data.
Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
| Trade Name | Adriforant |
| Generic | Adriforant |
| Adriforant Other Names | Adriforant, PF-03893787 |
| Type | |
| Formula | C13H22N6 |
| Weight | Average: 262.361 Monoisotopic: 262.190594732 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Adriforant
